Paul Quinn

Title: Paul Quinn: Innovator in Pharmaceutical Treatments

Introduction

Paul Quinn is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of conditions such as overactive bladder and irritable bowel syndrome. With a total of 2 patents to his name, Quinn's work has the potential to improve the quality of life for many patients.

Latest Patents

Quinn's latest patents include a formulation of darifenacin for use in the treatment of urgency induced by overactive bladder. This invention provides the use of darifenacin, or a pharmaceutically acceptable derivative thereof, in the manufacture of a medicament aimed at reducing urgency in patients suffering from overactive bladder. Additionally, he has developed a method for treating irritable bowel syndrome, which involves the multiple daily pulse dosing of an immediate release formulation of the anti-muscarinic darifenacin. Dosing two or three times a day is particularly preferred in this method.

Career Highlights

Throughout his career, Paul Quinn has worked with prominent companies in the pharmaceutical industry, including Warner Chilcott Company, LLC and Pfizer Corporation. His experience in these organizations has contributed to his expertise and innovative capabilities in drug development.

Collaborations

Quinn has collaborated with several professionals in his field, including Enrico Colli and Dzelal Serdarevic. These collaborations have likely enhanced his research and development efforts, leading to his successful patent applications.

Conclusion

In summary, Paul Quinn is an accomplished inventor whose work in pharmaceuticals has led to valuable innovations in the treatment of overactive bladder and irritable bowel syndrome. His contributions continue to impact the medical field positively.